Background Holistic approach to the clinical management pathway for malignancy of
undefined primary origin (MUO)/carcinoma of unknown primary (CUP) patients remains an …

Background: Patients presenting with malignancy of unknown origin (MUO) are
disadvantaged in many ways. The 2010 National Institute for Health and Care Excellence …

Abstract Background In the United Kingdom, national guidance published in 2010
recommended the establishment of specialist teams to improve clinical pathways for patients …

The latest clinical guidance from the National Institute for Health and Clinical Excellence
(NICE),'Diagnosis and management of metastatic malignant disease of unknown primary …

Background Carcinoma of unknown primary (CUP) remains an important tumor entity and a
disproportionate cause of cancer mortality. Little is known about the contemporary clinical …

Background Diagnosis and management of cancers of unknown primary (CUP) remain
challenging. This study examines the referral patterns, management and outcomes of …

Aim: To determine clinical practices in approach to management of CUP amongst Australian
medical oncologists Design: Cross-sectional survey design using an electronically …

CUP accounts for< 5% of cancers but, because of its high mortality rate, its relative
contribution to cancer deaths is higher. 1 The incidence of CUP has been declining …

This editorial calls for a strategic shift in our approach to cancers of unknown primary (CUP),
one that generates a comprehensive multidimensional portrait of cancer in patients with …

The concept of Cancer of Unknown Primary (CUP) has evolved with the advent of medical
oncology. CUP can be difficult to diagnose and represents 2 to 5% of new cancers, therefore …